EATG » News

Webinar: Results of the METRODORA research on the involvement of women in HIV clinical trials

EATG will host a webinar on the Results of the METRODORA research on the involvement of women in HIV clinical trials on Wednesday, 02 May 2018, 13:00 – 14:00 CEST…

Webinar: Introduction to medicine research and development

EATG will host a webinar, Introduction to medicine research and development, on Thursday, 26 April 2018, 18:00 – 19:00 CEST (Brussels, Berlin, Paris time). The webinar will be led by…

Positive Stories: the voices of women living with HIV across Europe

The EATG has launched a new initiative aiming to give women living with or affected by HIV a platform to make their voices heard. Positive Stories is an empowerment tool…

Grindr sharing the HIV status and other personal information of their users with third parties without their informed consent is unacceptable

The EATG is disturbed by the news, reported by BuzzFeed News, about Grindr sharing the HIV status information of their users with two third companies, Apptimize and Localytics. Such actions…

PARADIGM: A collaborative initiative on patient engagement kicks-off

PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines), a new initiative regarding patient engagement in research and development of medicines, was launched this week during…

STEP-UP 2018/19: Call for participants

The European AIDS Treatment Group (EATG) is happy to launch the call for participants for the STEP-UP 2018/19 training programme today. The STEP-UP programme is designed for people living with…

Metrodora: Webinar on women’s participation in HIV research

EATG will host a webinar on women’s participation in HIV research on 4 April 2018, 17:00 – 18:00 CET (Brussels, Berlin, Paris time). The webinar is organized within the context…

Civil society and patient organisations are seeking EU leadership and action on HIV, Hepatitis and TB

The European AIDS Treatment Group, along with other civil society and patients organisations, has co-signed an open letter to Commissioner Andriukaitis in view of the upcoming Staff Working Document on…

Organisations are urging Commissioner Andriukaitis to foster EU Member States’ response to Tuberculosis

In view of upcoming World Tuberculosis (TB) Day on March 24, the TB Europe Coalition, supported by 34 civil society and community organisations, urge Commissioner Andriukaitis to make a public…

Call for WHO & UNODC to revise guidelines on International Standards for the Treatment of Drug Use Disorders

The European AIDS Treatment Group together with 188 organisations has co-signed an open letter initiative by the International Network of People who use Drugs addressed to the WHO and UNODC…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

Webinar: Patient-reported Outcomes (PROs)

We invite you to join the webinar on What are patient-reported outcome measures and how are they used in drug development? taking place on Tuesday, 27 March 2018, 18:00 –…

THE EU CIVIL SOCIETY FORUM ON HIV, TB AND VIRAL HEPATITIS URGES THE EUROPEAN COMMISSION TO PRIORITIZE PUBLIC HEALTH WITHIN THE UPCOMING FINANCIAL FRAMEWORK

On 6 March the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the European Commission President Juncker, as well as Budget and Health Commissioners, in response to the…

Metrodora: Call for applications in the Multi-Stakeholders’ Meeting

Call for applications: Multi-Stakeholders’ Meeting Meaningful Engagement of Women in HIV Treatment Research Wednesday 16 May 2018, Park Inn Hotel, Brussels, Belgium   The Meeting: Within the framework of the…

The EU Civil Society Forum on HIV, TB and Viral Hepatitis calls the Romanian Ministry of Health to take on a leadership role on EU viral hepatitis policies

On 26 February, the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the Romanian Ministry of Health to request that it uses its convening power and…

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention,…

Community reception at CROI 2018

You are invited to the annual Community reception at CROI on 6 March 2018! For full details, please download the invitation for the event here: Community reception at CROI 2018,…

Presentations from the PrEP Summit now online

Organised jointly by EATG, AVAC, AIDSfonds, AIDES, AIDS Action Europe, NAM-AIDSMAP, NAT, Prepster, UNAIDS, WHO, the European PrEP Summit was organised in Amsterdam on 9-10 February 2018. The more than…

Advancing Community Agency – EATG Stakeholder Meeting in Brussels

The European AIDS Treatment Group held its annual Stakeholder Meeting in Brussels on 22 January 2018. The event welcomed 21 guests - partners and funders of EATG - who met…

M-Care 2018: Call for participants

The European AIDS Treatment Group (EATG) and the Africa Advocacy Foundation (AAF) are announcing a call for participants for the M-Care 2018 training programme. The goal of the training is…

Call for submission of country case studies on TB and HIV for thematic segment of the 42nd UNAIDS PCB

At its 41st meeting, the UNAIDS Program Coordinating Board (PCB) agreed that the theme for its 42nd meeting will be: “Ending tuberculosis and AIDS – a joint response in the…

WHO, partners recognize World Malaria Day theme, ‘Ready to beat malaria’

WHO: World Malaria Day 2018: Ready to beat malaria “WHO joins partner organizations in promoting this year’s World Malaria Day theme, ‘Ready to beat malaria.’ This theme underscores the collective…

World at risk of losing control of HIV and AIDS epidemic, PEPFAR architect says

WASHINGTON — The HIV and AIDS epidemic could become uncontained if current funding trends continue, warned one of the founding architects of the United States President’s Emergency Plan for AIDS…

Choice of Bay Area for AIDS conference exposes tension among activists

After George Ayala learned last month that San Francisco and Oakland had been chosen to co-host the International AIDS Conference in 2020, he quickly published a statement of disapproval. Ayala,…

Anti-HIV drug combination does not increase preterm birth risk, study suggests

NIH-funded study could allay concerns about regimens containing TDF. A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the…

BHIVA/BASHH conference: What are the outcomes for adults who were born with HIV?

Among people who were born with HIV and have now transitioned to adult care at St Mary’s hospital in London, 80% have an undetectable viral load, rising to 87% in…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 335 of the “Global Fund Observer.” The newsletter includes articles…

Possible inhibitory effect of HCV-induced steatogenesis by HBV

There may be an inhibitory effect of hepatitis C virus (HCV)-induced steatogenesis by hepatitis B virus (HBV) in certain subgroups of patients, according to a large, multicenter, retrospective cohort study…

News from the Fourth Joint Conference of BHIVA with BASHH

The Fourth Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH) was held on 17-20 April 2018 in Edinburgh, UK. *********************…

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. As CROI is a conference that keeps on giving, this issue of HTB continues with further reports from…

Hepatitis C positive organ donors — coming soon to a transplant center near you

There’s one immutable fact in solid organ transplantation — the number of patients awaiting transplant exceeds the number of available organs. This shortage means that ethical, medically safe strategies to increase…

VBI Vaccines announces completion of enrollment in PROTECT Phase 3 clinical study for Sci-B-Vac® hepatitis B vaccine

-- More than 1,600 subjects enrolled in PROTECT study -- Topline data expected mid-2019 CAMBRIDGE, Mass., April 19, 2018 -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”) today announced the completion of…

ACIP recommends Heplisav-B vaccine for adults

Heplisav-B (HepB-CpG; Dynavax Technologies Corporation), a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on…

Hepatitis news

Hepatitis C Infectious Disease Advisor: Glecaprevir/pibrentasvir highly efficacious for HCV/HIV coinfection Infectious Disease Advisor: Reduced risk of hepatocellular carcinoma in DAA-treated HCV infection MD Magazine: Hepatitis C-linked kidney disease improves…

An historic opportunity to end AIDS in Africa

A decade of progress has inspired the once unthinkable—that the AIDS epidemic can be ended as a public health threat. A decade of transformation has set the stage, and the…

Theratechnologies to seek regulatory approval of Trogarzo™ in Europe

Theratechnologies to seek regulatory approval of Trogarzo™ (ibalizumab) in Europe based on efficacy and safety data used for FDA approval MONTREAL, April 24, 2018 -- Theratechnologies Inc. (Theratechnologies) today announced…

Gene-edited stem cells show promise against HIV in non-human primates

Edited cells reduce size of 'viral reservoirs' that could reactivate to produce more virus copies Gene editing of bone marrow stem cells in pigtail macaques infected with simian/human immunodeficiency virus…

Excessive online support can be harmful to HIV patients

From the beginning of the internet era, both HIV-positive people and heath care providers alike have sought medical information online. Over the course of the HIV epidemic, web-based platforms have…

The evolution of antiretroviral therapy: past, present, and future

On June 5th, 1981, the United States Centers for Disease Control and Prevention (CDC) published a Morbidity and Mortality Weekly Report (MMWR), describing five cases of a rare lung infection,…

Patients with HIV face increased risk of mortality from lung cancer